Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Metabolic Syndrome Revenue 1.4 Market Analysis by Type 1.4.1 Global Metabolic Syndrome Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Diabetes 1.4.3 Obesity 1.4.4 Hypercholesterolemia 1.4.5 Lysosomal storage diseases 1.5 Market by Application 1.5.1 Global Metabolic Syndrome Market Share by Application: 2020 VS 2026 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Metabolic Syndrome Market Perspective (2015-2026) 2.2 Metabolic Syndrome Growth Trends by Regions 2.2.1 Metabolic Syndrome Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Metabolic Syndrome Historic Market Share by Regions (2015-2020) 2.2.3 Metabolic Syndrome Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Metabolic Syndrome Market Growth Strategy 2.3.6 Primary Interviews with Key Metabolic Syndrome Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Metabolic Syndrome Players by Market Size 3.1.1 Global Top Metabolic Syndrome Players by Revenue (2015-2020) 3.1.2 Global Metabolic Syndrome Revenue Market Share by Players (2015-2020) 3.1.3 Global Metabolic Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Metabolic Syndrome Market Concentration Ratio 3.2.1 Global Metabolic Syndrome Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Metabolic Syndrome Revenue in 2019 3.3 Metabolic Syndrome Key Players Head office and Area Served 3.4 Key Players Metabolic Syndrome Product Solution and Service 3.5 Date of Enter into Metabolic Syndrome Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Metabolic Syndrome Historic Market Size by Type (2015-2020) 4.2 Global Metabolic Syndrome Forecasted Market Size by Type (2021-2026) 5 Metabolic Syndrome Breakdown Data by Application (2015-2026) 5.1 Global Metabolic Syndrome Market Size by Application (2015-2020) 5.2 Global Metabolic Syndrome Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Metabolic Syndrome Market Size (2015-2020) 6.2 Metabolic Syndrome Key Players in North America (2019-2020) 6.3 North America Metabolic Syndrome Market Size by Type (2015-2020) 6.4 North America Metabolic Syndrome Market Size by Application (2015-2020) 7 Europe 7.1 Europe Metabolic Syndrome Market Size (2015-2020) 7.2 Metabolic Syndrome Key Players in Europe (2019-2020) 7.3 Europe Metabolic Syndrome Market Size by Type (2015-2020) 7.4 Europe Metabolic Syndrome Market Size by Application (2015-2020) 8 China 8.1 China Metabolic Syndrome Market Size (2015-2020) 8.2 Metabolic Syndrome Key Players in China (2019-2020) 8.3 China Metabolic Syndrome Market Size by Type (2015-2020) 8.4 China Metabolic Syndrome Market Size by Application (2015-2020) 9 Japan 9.1 Japan Metabolic Syndrome Market Size (2015-2020) 9.2 Metabolic Syndrome Key Players in Japan (2019-2020) 9.3 Japan Metabolic Syndrome Market Size by Type (2015-2020) 9.4 Japan Metabolic Syndrome Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Metabolic Syndrome Market Size (2015-2020) 10.2 Metabolic Syndrome Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Metabolic Syndrome Market Size by Type (2015-2020) 10.4 Southeast Asia Metabolic Syndrome Market Size by Application (2015-2020) 11 India 11.1 India Metabolic Syndrome Market Size (2015-2020) 11.2 Metabolic Syndrome Key Players in India (2019-2020) 11.3 India Metabolic Syndrome Market Size by Type (2015-2020) 11.4 India Metabolic Syndrome Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Metabolic Syndrome Market Size (2015-2020) 12.2 Metabolic Syndrome Key Players in Central & South America (2019-2020) 12.3 Central & South America Metabolic Syndrome Market Size by Type (2015-2020) 12.4 Central & South America Metabolic Syndrome Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Novo Nordisk 13.1.1 Novo Nordisk Company Details 13.1.2 Novo Nordisk Business Overview and Its Total Revenue 13.1.3 Novo Nordisk Metabolic Syndrome Introduction 13.1.4 Novo Nordisk Revenue in Metabolic Syndrome Business (2015-2020)) 13.1.5 Novo Nordisk Recent Development 13.2 Sanofi 13.2.1 Sanofi Company Details 13.2.2 Sanofi Business Overview and Its Total Revenue 13.2.3 Sanofi Metabolic Syndrome Introduction 13.2.4 Sanofi Revenue in Metabolic Syndrome Business (2015-2020) 13.2.5 Sanofi Recent Development 13.3 Merck 13.3.1 Merck Company Details 13.3.2 Merck Business Overview and Its Total Revenue 13.3.3 Merck Metabolic Syndrome Introduction 13.3.4 Merck Revenue in Metabolic Syndrome Business (2015-2020) 13.3.5 Merck Recent Development 13.4 AstraZeneca 13.4.1 AstraZeneca Company Details 13.4.2 AstraZeneca Business Overview and Its Total Revenue 13.4.3 AstraZeneca Metabolic Syndrome Introduction 13.4.4 AstraZeneca Revenue in Metabolic Syndrome Business (2015-2020) 13.4.5 AstraZeneca Recent Development 13.5 Eli Lily 13.5.1 Eli Lily Company Details 13.5.2 Eli Lily Business Overview and Its Total Revenue 13.5.3 Eli Lily Metabolic Syndrome Introduction 13.5.4 Eli Lily Revenue in Metabolic Syndrome Business (2015-2020) 13.5.5 Eli Lily Recent Development 13.6 AbbVie 13.6.1 AbbVie Company Details 13.6.2 AbbVie Business Overview and Its Total Revenue 13.6.3 AbbVie Metabolic Syndrome Introduction 13.6.4 AbbVie Revenue in Metabolic Syndrome Business (2015-2020) 13.6.5 AbbVie Recent Development 13.7 Actelion Pharmaceuticals 13.7.1 Actelion Pharmaceuticals Company Details 13.7.2 Actelion Pharmaceuticals Business Overview and Its Total Revenue 13.7.3 Actelion Pharmaceuticals Metabolic Syndrome Introduction 13.7.4 Actelion Pharmaceuticals Revenue in Metabolic Syndrome Business (2015-2020) 13.7.5 Actelion Pharmaceuticals Recent Development 13.8 Adocia 13.8.1 Adocia Company Details 13.8.2 Adocia Business Overview and Its Total Revenue 13.8.3 Adocia Metabolic Syndrome Introduction 13.8.4 Adocia Revenue in Metabolic Syndrome Business (2015-2020) 13.8.5 Adocia Recent Development 13.9 Aegerion Pharmaceuticals 13.9.1 Aegerion Pharmaceuticals Company Details 13.9.2 Aegerion Pharmaceuticals Business Overview and Its Total Revenue 13.9.3 Aegerion Pharmaceuticals Metabolic Syndrome Introduction 13.9.4 Aegerion Pharmaceuticals Revenue in Metabolic Syndrome Business (2015-2020) 13.9.5 Aegerion Pharmaceuticals Recent Development 13.10 Akros Pharma 13.10.1 Akros Pharma Company Details 13.10.2 Akros Pharma Business Overview and Its Total Revenue 13.10.3 Akros Pharma Metabolic Syndrome Introduction 13.10.4 Akros Pharma Revenue in Metabolic Syndrome Business (2015-2020) 13.10.5 Akros Pharma Recent Development 13.11 Alnylam Pharmaceuticals 10.11.1 Alnylam Pharmaceuticals Company Details 10.11.2 Alnylam Pharmaceuticals Business Overview and Its Total Revenue 10.11.3 Alnylam Pharmaceuticals Metabolic Syndrome Introduction 10.11.4 Alnylam Pharmaceuticals Revenue in Metabolic Syndrome Business (2015-2020) 10.11.5 Alnylam Pharmaceuticals Recent Development 13.12 Amarin 10.12.1 Amarin Company Details 10.12.2 Amarin Business Overview and Its Total Revenue 10.12.3 Amarin Metabolic Syndrome Introduction 10.12.4 Amarin Revenue in Metabolic Syndrome Business (2015-2020) 10.12.5 Amarin Recent Development 13.13 nAmgen 10.13.1 nAmgen Company Details 10.13.2 nAmgen Business Overview and Its Total Revenue 10.13.3 nAmgen Metabolic Syndrome Introduction 10.13.4 nAmgen Revenue in Metabolic Syndrome Business (2015-2020) 10.13.5 nAmgen Recent Development 13.14 Amicus Therapeutics 10.14.1 Amicus Therapeutics Company Details 10.14.2 Amicus Therapeutics Business Overview and Its Total Revenue 10.14.3 Amicus Therapeutics Metabolic Syndrome Introduction 10.14.4 Amicus Therapeutics Revenue in Metabolic Syndrome Business (2015-2020) 10.14.5 Amicus Therapeutics Recent Development 13.15 Arbutus Biopharma 10.15.1 Arbutus Biopharma Company Details 10.15.2 Arbutus Biopharma Business Overview and Its Total Revenue 10.15.3 Arbutus Biopharma Metabolic Syndrome Introduction 10.15.4 Arbutus Biopharma Revenue in Metabolic Syndrome Business (2015-2020) 10.15.5 Arbutus Biopharma Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Metabolic Syndrome Key Market Segments Table 2. Key Players Covered: Ranking by Metabolic Syndrome Revenue Table 3. Ranking of Global Top Metabolic Syndrome Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Metabolic Syndrome Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Diabetes Table 6. Key Players of Obesity Table 7. Key Players of Hypercholesterolemia Table 8. Key Players of Lysosomal storage diseases Table 9. Global Metabolic Syndrome Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 10. Global Metabolic Syndrome Market Size by Regions (US$ Million): 2020 VS 2026 Table 11. Global Metabolic Syndrome Market Size by Regions (2015-2020) (US$ Million) Table 12. Global Metabolic Syndrome Market Share by Regions (2015-2020) Table 13. Global Metabolic Syndrome Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 14. Global Metabolic Syndrome Market Share by Regions (2021-2026) Table 15. Market Top Trends Table 16. Key Drivers: Impact Analysis Table 17. Key Challenges Table 18. Metabolic Syndrome Market Growth Strategy Table 19. Main Points Interviewed from Key Metabolic Syndrome Players Table 20. Global Metabolic Syndrome Revenue by Players (2015-2020) (Million US$) Table 21. Global Metabolic Syndrome Market Share by Players (2015-2020) Table 22. Global Top Metabolic Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabolic Syndrome as of 2019) Table 23. Global Metabolic Syndrome by Players Market Concentration Ratio (CR5 and HHI) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Metabolic Syndrome Product Solution and Service Table 26. Date of Enter into Metabolic Syndrome Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Metabolic Syndrome Market Size by Type (2015-2020) (Million US$) Table 29. Global Metabolic Syndrome Market Size Share by Type (2015-2020) Table 30. Global Metabolic Syndrome Revenue Market Share by Type (2021-2026) Table 31. Global Metabolic Syndrome Market Size Share by Application (2015-2020) Table 32. Global Metabolic Syndrome Market Size by Application (2015-2020) (Million US$) Table 33. Global Metabolic Syndrome Market Size Share by Application (2021-2026) Table 34. North America Key Players Metabolic Syndrome Revenue (2019-2020) (Million US$) Table 35. North America Key Players Metabolic Syndrome Market Share (2019-2020) Table 36. North America Metabolic Syndrome Market Size by Type (2015-2020) (Million US$) Table 37. North America Metabolic Syndrome Market Share by Type (2015-2020) Table 38. North America Metabolic Syndrome Market Size by Application (2015-2020) (Million US$) Table 39. North America Metabolic Syndrome Market Share by Application (2015-2020) Table 40. Europe Key Players Metabolic Syndrome Revenue (2019-2020) (Million US$) Table 41. Europe Key Players Metabolic Syndrome Market Share (2019-2020) Table 42. Europe Metabolic Syndrome Market Size by Type (2015-2020) (Million US$) Table 43. Europe Metabolic Syndrome Market Share by Type (2015-2020) Table 44. Europe Metabolic Syndrome Market Size by Application (2015-2020) (Million US$) Table 45. Europe Metabolic Syndrome Market Share by Application (2015-2020) Table 46. China Key Players Metabolic Syndrome Revenue (2019-2020) (Million US$) Table 47. China Key Players Metabolic Syndrome Market Share (2019-2020) Table 48. China Metabolic Syndrome Market Size by Type (2015-2020) (Million US$) Table 49. China Metabolic Syndrome Market Share by Type (2015-2020) Table 50. China Metabolic Syndrome Market Size by Application (2015-2020) (Million US$) Table 51. China Metabolic Syndrome Market Share by Application (2015-2020) Table 52. Japan Key Players Metabolic Syndrome Revenue (2019-2020) (Million US$) Table 53. Japan Key Players Metabolic Syndrome Market Share (2019-2020) Table 54. Japan Metabolic Syndrome Market Size by Type (2015-2020) (Million US$) Table 55. Japan Metabolic Syndrome Market Share by Type (2015-2020) Table 56. Japan Metabolic Syndrome Market Size by Application (2015-2020) (Million US$) Table 57. Japan Metabolic Syndrome Market Share by Application (2015-2020) Table 58. Southeast Asia Key Players Metabolic Syndrome Revenue (2019-2020) (Million US$) Table 59. Southeast Asia Key Players Metabolic Syndrome Market Share (2019-2020) Table 60. Southeast Asia Metabolic Syndrome Market Size by Type (2015-2020) (Million US$) Table 61. Southeast Asia Metabolic Syndrome Market Share by Type (2015-2020) Table 62. Southeast Asia Metabolic Syndrome Market Size by Application (2015-2020) (Million US$) Table 63. Southeast Asia Metabolic Syndrome Market Share by Application (2015-2020) Table 64. India Key Players Metabolic Syndrome Revenue (2019-2020) (Million US$) Table 65. India Key Players Metabolic Syndrome Market Share (2019-2020) Table 66. India Metabolic Syndrome Market Size by Type (2015-2020) (Million US$) Table 67. India Metabolic Syndrome Market Share by Type (2015-2020) Table 68. India Metabolic Syndrome Market Size by Application (2015-2020) (Million US$) Table 69. India Metabolic Syndrome Market Share by Application (2015-2020) Table 70. Central & South America Key Players Metabolic Syndrome Revenue (2019-2020) (Million US$) Table 71. Central & South America Key Players Metabolic Syndrome Market Share (2019-2020) Table 72. Central & South America Metabolic Syndrome Market Size by Type (2015-2020) (Million US$) Table 73. Central & South America Metabolic Syndrome Market Share by Type (2015-2020) Table 74. Central & South America Metabolic Syndrome Market Size by Application (2015-2020) (Million US$) Table 75. Central & South America Metabolic Syndrome Market Share by Application (2015-2020) Table 76. Novo Nordisk Company Details Table 77. Novo Nordisk Business Overview Table 78. Novo Nordisk Product Table 79. Novo Nordisk Revenue in Metabolic Syndrome Business (2015-2020) (Million US$) Table 80. Novo Nordisk Recent Development Table 81. Sanofi Company Details Table 82. Sanofi Business Overview Table 83. Sanofi Product Table 84. Sanofi Revenue in Metabolic Syndrome Business (2015-2020) (Million US$) Table 85. Sanofi Recent Development Table 86. Merck Company Details Table 87. Merck Business Overview Table 88. Merck Product Table 89. Merck Revenue in Metabolic Syndrome Business (2015-2020) (Million US$) Table 90. Merck Recent Development Table 91. AstraZeneca Company Details Table 92. AstraZeneca Business Overview Table 93. AstraZeneca Product Table 94. AstraZeneca Revenue in Metabolic Syndrome Business (2015-2020) (Million US$) Table 95. AstraZeneca Recent Development Table 96. Eli Lily Company Details Table 97. Eli Lily Business Overview Table 98. Eli Lily Product Table 99. Eli Lily Revenue in Metabolic Syndrome Business (2015-2020) (Million US$) Table 100. Eli Lily Recent Development Table 101. AbbVie Company Details Table 102. AbbVie Business Overview Table 103. AbbVie Product Table 104. AbbVie Revenue in Metabolic Syndrome Business (2015-2020) (Million US$) Table 105. AbbVie Recent Development Table 106. Actelion Pharmaceuticals Company Details Table 107. Actelion Pharmaceuticals Business Overview Table 108. Actelion Pharmaceuticals Product Table 109. Actelion Pharmaceuticals Revenue in Metabolic Syndrome Business (2015-2020) (Million US$) Table 110. Actelion Pharmaceuticals Recent Development Table 111. Adocia Business Overview Table 112. Adocia Product Table 113. Adocia Company Details Table 114. Adocia Revenue in Metabolic Syndrome Business (2015-2020) (Million US$) Table 115. Adocia Recent Development Table 116. Aegerion Pharmaceuticals Company Details Table 117. Aegerion Pharmaceuticals Business Overview Table 118. Aegerion Pharmaceuticals Product Table 119. Aegerion Pharmaceuticals Revenue in Metabolic Syndrome Business (2015-2020) (Million US$) Table 120. Aegerion Pharmaceuticals Recent Development Table 121. Akros Pharma Company Details Table 122. Akros Pharma Business Overview Table 123. Akros Pharma Product Table 124. Akros Pharma Revenue in Metabolic Syndrome Business (2015-2020) (Million US$) Table 125. Akros Pharma Recent Development Table 126. Alnylam Pharmaceuticals Company Details Table 127. Alnylam Pharmaceuticals Business Overview Table 128. Alnylam Pharmaceuticals Product Table 129. Alnylam Pharmaceuticals Revenue in Metabolic Syndrome Business (2015-2020) (Million US$) Table 130. Alnylam Pharmaceuticals Recent Development Table 131. Amarin Company Details Table 132. Amarin Business Overview Table 133. Amarin Product Table 134. Amarin Revenue in Metabolic Syndrome Business (2015-2020) (Million US$) Table 135. Amarin Recent Development Table 136. nAmgen Company Details Table 137. nAmgen Business Overview Table 138. nAmgen Product Table 139. nAmgen Revenue in Metabolic Syndrome Business (2015-2020) (Million US$) Table 140. nAmgen Recent Development Table 141. Amicus Therapeutics Company Details Table 142. Amicus Therapeutics Business Overview Table 143. Amicus Therapeutics Product Table 144. Amicus Therapeutics Revenue in Metabolic Syndrome Business (2015-2020) (Million US$) Table 145. Amicus Therapeutics Recent Development Table 146. Arbutus Biopharma Company Details Table 147. Arbutus Biopharma Business Overview Table 148. Arbutus Biopharma Product Table 149. Arbutus Biopharma Revenue in Metabolic Syndrome Business (2015-2020) (Million US$) Table 150. Arbutus Biopharma Recent Development Table 151. Research Programs/Design for This Report Table 152. Key Data Information from Secondary Sources Table 153. Key Data Information from Primary Sources List of Figures Figure 1. Global Metabolic Syndrome Market Share by Type: 2020 VS 2026 Figure 2. Diabetes Features Figure 3. Obesity Features Figure 4. Hypercholesterolemia Features Figure 5. Lysosomal storage diseases Features Figure 6. Global Metabolic Syndrome Market Share by Application: 2020 VS 2026 Figure 7. Hospital Case Studies Figure 8. Clinic Case Studies Figure 9. Others Case Studies Figure 10. Metabolic Syndrome Report Years Considered Figure 11. Global Metabolic Syndrome Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Metabolic Syndrome Market Share by Regions: 2020 VS 2026 Figure 13. Global Metabolic Syndrome Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Metabolic Syndrome Market Share by Players in 2019 Figure 16. Global Top Metabolic Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabolic Syndrome as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Metabolic Syndrome Revenue in 2019 Figure 18. North America Metabolic Syndrome Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Metabolic Syndrome Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China Metabolic Syndrome Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan Metabolic Syndrome Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia Metabolic Syndrome Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India Metabolic Syndrome Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America Metabolic Syndrome Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Novo Nordisk Revenue Growth Rate in Metabolic Syndrome Business (2015-2020) Figure 27. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Sanofi Revenue Growth Rate in Metabolic Syndrome Business (2015-2020) Figure 29. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Merck Revenue Growth Rate in Metabolic Syndrome Business (2015-2020) Figure 31. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. AstraZeneca Revenue Growth Rate in Metabolic Syndrome Business (2015-2020) Figure 33. Eli Lily Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Eli Lily Revenue Growth Rate in Metabolic Syndrome Business (2015-2020) Figure 35. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. AbbVie Revenue Growth Rate in Metabolic Syndrome Business (2015-2020) Figure 37. Actelion Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Actelion Pharmaceuticals Revenue Growth Rate in Metabolic Syndrome Business (2015-2020) Figure 39. Adocia Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Adocia Revenue Growth Rate in Metabolic Syndrome Business (2015-2020) Figure 41. Aegerion Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Aegerion Pharmaceuticals Revenue Growth Rate in Metabolic Syndrome Business (2015-2020) Figure 43. Akros Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Akros Pharma Revenue Growth Rate in Metabolic Syndrome Business (2015-2020) Figure 45. Alnylam Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. Alnylam Pharmaceuticals Revenue Growth Rate in Metabolic Syndrome Business (2015-2020) Figure 47. Amarin Total Revenue (US$ Million): 2019 Compared with 2018 Figure 48. Amarin Revenue Growth Rate in Metabolic Syndrome Business (2015-2020) Figure 49. nAmgen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 50. nAmgen Revenue Growth Rate in Metabolic Syndrome Business (2015-2020) Figure 51. Amicus Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 52. Amicus Therapeutics Revenue Growth Rate in Metabolic Syndrome Business (2015-2020) Figure 53. Arbutus Biopharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 54. Arbutus Biopharma Revenue Growth Rate in Metabolic Syndrome Business (2015-2020) Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Novo Nordisk Sanofi Merck AstraZeneca Eli Lily AbbVie Actelion Pharmaceuticals Adocia Aegerion Pharmaceuticals Akros Pharma Alnylam Pharmaceuticals Amarin nAmgen Amicus Therapeutics Arbutus Biopharma